Telesis Bio, Inc. provided earnings guidance for 2023. For the period, the company announced that based on current economic and product trends observed in its core markets, the Company now believes that revenue for fiscal 2023 is estimated to be between $28.0 and $30.0 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.12 USD | -15.20% | -13.80% | -28.71% |
05-09 | Earnings Flash (TBIO) TELESIS BIO Reports Q1 Revenue $3.4M | MT |
05-09 | Telesis Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.71% | 8.56M | |
+11.73% | 226B | |
+9.53% | 188B | |
+14.63% | 137B | |
+27.47% | 108B | |
-0.04% | 63.19B | |
+13.73% | 52.26B | |
+4.86% | 51B | |
+7.72% | 43.89B | |
+7.86% | 38.07B |
- Stock Market
- Equities
- TBIO Stock
- News Telesis Bio, Inc.
- Telesis Bio, Inc. Provides Earnings Guidance for 2023